BACKGROUND Passive immunotherapy with convalescent plasma (CP) is a potential
treatment for COVID-19. Evidence from controlled clinical trials is inconclusive. METHODS We …

Background Spain is one of the European countries most affected by the COVID-19 pandemic.
Serological surveys are a valuable tool to assess the extent of the epidemic, given the …

Hepatitis B virus (HBV) genotypes were examined in HIV-infected patients with chronic HBV
infection seen in our clinic during 2002. A total of 28 of 1100 individuals (prevalence 2.5%) …

The response to standard or pegylated interferon (IFN) plus ribavirin (RBV) seems to be
lower in hepatitis C virus (HCV)/HIV-coinfected subjects than in HCV-monoinfected patients. …

Background To date, no immunological data on COVID-19 heterologous vaccination schedules
in humans have been reported. We assessed the immunogenicity and reactogenicity of …

HIV-1 can infect both activated and resting, non-dividing cells, following which the viral genome
can be permanently integrated into a host cell chromosome. Latent HIV-1 reservoirs are …

Objective To estimate the infection fatality risk for severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), based on deaths with confirmed coronavirus disease 2019 (covid-19) …

Background: Treatment of hepatitis C virus (HCV) has become a major challenge in HIV-infected
individuals. No data exist on the efficacy and tolerability of pegylated IFN (peg-IFN) plus …

Background Passive immunotherapy with convalescent plasma (CP) is a potential treatment
for COVID-19 for which evidence from controlled clinical trials is lacking. Methods We …

Cases of West Nile neuroinvasive disease (WNND) in Spain increased in summer 2020.
Here we report on this increase and the local, regional and national public health measures …